* Prices do not include VAT
Click here if you want to proceed with a manual invoice instead of the online payment procedure.
TRANSFAC Diseases includes the full functionality of TRANSFAC Pathways with its renowned manually curated database of eukaryotic transcription factors, their genomic binding sites and DNA-binding profiles, together with the comprehensive knowledge base on signal transduction and metabolic pathways, as well as the Gene-Disease-Drug-Clinical Trial assignments, disease biomarkers, drug targets, and drug-disease approval status.
A comprehensive solution for gene regulation analysis covering more than 300 species, with a focus on Human, Mouse, Rat, Drosophila, Zebrafish, Yeast, and plants where emphasis is on Arabidopsis, Soybean and Rice.
Access to the unique MATCH Suite tool (Human only) for identification of transcription factors regulating the human gene(s) of your interest in the specified conditions.
Interactive search engine providing access to world’s largest manually curated encyclopedia of transcriptional regulation, as well as comprehensive knowledge base on signal transduction and metabolic pathways, individual reactions with experimental details, protein-protein interactions and post-translational modifications, together with the information on Gene-Disease-Drug-Clinical Trial assignments, disease biomarkers, drug targets, and drug-disease approval status.
Upstream Analysis – integrated promoter and pathway analysis.
Deep understanding of molecular mechanisms underlying the studied pathology.
Prospective treatments suggestions covering both: known and repurposed drugs for the studied pathology in complicated clinical cases where no conventional therapies are effective.
Automatically generated comprehensive report fully explaining the performed analysis and the obtained results.
Molecular Tumor Board report based on patient’s genomics data supported for a number of neoplasm diseases.
Customers from EU countries are required to provide their VAT number. Select "Other" if you are not a EU resident.